Constellation Brands Updates Fiscal 2026 Outlook
Globenewswire· 2025-09-02 11:30
Updates reported EPS guidance to $10.77 - $11.07 and comparable EPS guidance to $11.30 - $11.60 (1) Updates Enterprise organic net sales to decline (6)% - (4)%, reported operating income to grow 666% - 686% and comparable operating income to decline (11)% - (9)% Updates Beer net sales to decline (4)% - (2)% and Beer operating income to decline (9)% - (7)% ROCHESTER, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today updates to ...
NextEra Energy to meet with investors throughout September and in early October
Prnewswire· 2025-09-02 11:30
This news release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but instead represent the current expectations of NextEra Energy, Inc. (NextEra Energy) and Florida Power & Light Company (FPL) regarding future operating results and other future events, many of which, by their nature, are inherently uncertain and outside of NextEra Energy's and FP ...
BitMine Immersion (BMNR) Announces Release of August Investor Presentation and Latest Video Message from Tom Lee, Chairman
Prnewswire· 2025-09-02 11:30
BMNR investor presentation walks you through "the Alchemy of 5%" BitMine Crypto + Cash Holdings of $8.98 billion, including 1.87 million ETH Tokens BitMine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, and Galaxy Digital to support BitMine's goal of acquiring 5% of ETH LAS VEGAS, Sept. 2, 2025 /PRNewswire/ -- (NYSE AMERICAN: BMNR) BitMine Immersion Technologies ("BitMine" or the "Company") today ann ...
Glass Lewis Recommends Shareholders Vote FOR DallasNews' Merger with Hearst
Globenewswire· 2025-09-02 11:30
Independent Proxy Advisor Confirms Hearst Merger Delivers Certain and Immediate Value for Shareholders at a Substantial Premium Glass Lewis Believes Proposed Terms of Hearst Merger Approximate the Maximum Value Available DallasNews Board Recommends Shareholders Vote FOR the Hearst Merger to Secure a Certain and Significant Premium DALLAS, Sept. 02, 2025 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) (the “Company” or “DallasNews”), the holding company of The Dallas Morning News and Medium Giant, ...
Conagra Brands to Release Fiscal 2026 First Quarter Earnings on October 1, 2025
Prnewswire· 2025-09-02 11:30
CHICAGO, Sept. 2, 2025 /PRNewswire/ -- Conagra Brands, Inc. (NYSE: CAG) will release its fiscal 2026 first quarter results on Wednesday, October 1, 2025. A press release and supplemental materials, including pre-recorded remarks, will be issued that morning prior to a 30-minute live question-and-answer session with the investment community at 9:30 a.m. ET.The pre-recorded remarks, transcript, press release, presentation slides, and live audio Q&A can be accessed at conagrabrands.com/investor-relations under ...
CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
Globenewswire· 2025-09-02 11:30
- Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential - - Revised guidance of pro forma 2025 combined revenues, now estimated to be in the range of $325 to $350 million - - Transaction expected to be near-term accretive to EPS with double-digit accretion expected in 2026; annual run-rate synergies expected to be ~$35 to $45 million - BERKELEY HEI ...
Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Prnewswire· 2025-09-02 11:30
PRINCETON, N.J., Sept. 2, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Christopher J. Schaber, Ph.D., President and Chief Executive Officer, has been invited to deliver a corporate presentation at the upcoming H.C. Wainwright 27th Annual Global Investment Conference. The conference will be held September ...
Scinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet
Prnewswire· 2025-09-02 11:30
JERUSALEM, Sept. 2, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing novel and innovative biological drug candidates for the treatment of inflammation and immunology (I&I) related diseases and on providing CDMO services through its Scinai Bioservices business unit, today announced its financial results for the six months ended June 30, 2025.Six-Month 2025 Financial Summary Revenues for the six months ended Jun ...
Kevin Guest Encourages Self-Improvement as Path to Harmony, Fulfillment
Prnewswire· 2025-09-02 11:27
USANA Health Sciences Executive Chairman Shares Insights for September's Self-Improvement Month SALT LAKE CITY, Sept. 2, 2025 /PRNewswire/ -- In celebration of September's Self-Improvement Month, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is inspiring individuals to take meaningful steps toward personal growth and self-betterment. With the U.S. self-improvement industry valued at $12 billion annually, this month is a reminder that the journey to becoming our best selves is both a ...
Buy AVGO Stock Ahead of Its Upcoming Earnings?
Forbes· 2025-09-02 11:25
SUQIAN, CHINA - MARCH 9, 2025 - An illustration photo shows the Broadcom LOGO displayed on a smartphone in Suqian, Jiangsu province, China on March 9, 2025. (Photo credit should read CFOTO/Future Publishing via Getty Images)CFOTO/Future Publishing via Getty ImagesBroadcom (NASDAQ: AVGO) is set to announce its earnings on Thursday, September 4, 2025. Historical records indicate that purchasing AVGO stock prior to the earnings announcement has often been a successful strategy. In the past five years, the stoc ...